Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer
Sotorasib and panitumumab demonstrate clinically meaningful benefit in KRAS G12C-mutated metastatic colorectal cancer
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Cost-benefit analysis of new cancer medicines: The difficult choices of governments
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
OncoAlert Round Up for September 22-28, 2023
Early-stage breast cancer detection in breast milk
OncoAlert Round Up for September 15-21, 2023